Skip to main content
. 2014 Jan 23;99(4):1322–1329. doi: 10.1210/jc.2013-4105

Table 2.

Number of Subjects in Each Randomization Group Experiencing Adverse Effects

No. of Subjects
Teriparatide (n = 10) Placebo (n = 11)
Lightheadedness 4 6
Muscle pain or spasm 3 4
Nausea 1 5
Vomiting 1 3
Headache 6 5
Injection site ecchymoses, bruising, erythema 6 9
Serum Ca above normal range 2 0
24-h urine calcium >400 mg 3 1